These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17786723)

  • 1. Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.
    McClune B; Buadi FK; Aslam N; Przepiorka D
    Leuk Lymphoma; 2007 Sep; 48(9):1849-51. PubMed ID: 17786723
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.
    Bassan R; Masciulli A; Intermesoli T; Audisio E; Rossi G; Pogliani EM; Cassibba V; Mattei D; Romani C; Cortelezzi A; Corti C; Scattolin AM; Spinelli O; Tosi M; Parolini M; Marmont F; Borlenghi E; Fumagalli M; Cortelazzo S; Gallamini A; Marfisi RM; Oldani E; Rambaldi A
    Haematologica; 2015 Jun; 100(6):786-93. PubMed ID: 25749825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions.
    Parasole R; Menna G; Marra N; Petruzziello F; Locatelli F; Mangione A; Misuraca A; Buffardi S; Di Cesare-Merlone A; Poggi V
    Leuk Lymphoma; 2008 Aug; 49(8):1553-9. PubMed ID: 18766969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
    Parasole R; Petruzziello F; Messina C; Barisone E; Pession A; Locatelli F; Micalizzi C; Cesaro S; Testi AM; De Matteo A; Varotto S; Berger M; Morello W; Menna G; Poggi V
    Leuk Lymphoma; 2015 Mar; 56(3):650-5. PubMed ID: 24882262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.
    Valentin A; Troppan K; Pfeilstöcker M; Nösslinger T; Linkesch W; Neumeister P
    Leuk Lymphoma; 2014 Aug; 55(8):1739-42. PubMed ID: 24138308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma.
    Spina M; Chimienti E; Martellotta F; Vaccher E; Berretta M; Zanet E; Lleshi A; Canzonieri V; Bulian P; Tirelli U
    Cancer; 2010 Mar; 116(6):1495-501. PubMed ID: 20108270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases.
    Sancho JM; Ribera JM; Romero MJ; Martín-Reina V; Giraldo P; Ruiz E
    Haematologica; 2006 Mar; 91(3):ECR02. PubMed ID: 16533729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.
    Levinsen M; Harila-Saari A; Grell K; Jonsson OG; Taskinen M; Abrahamsson J; Vettenranta K; Åsberg A; Risteli J; Heldrup J; Schmiegelow K
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):602-609. PubMed ID: 27571129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric detection of liposomal cytarabine in cerebrospinal fluid of patients treated with intrathecal chemotherapy.
    Stacchini A; Demurtas A; Aliberti S
    Cytometry B Clin Cytom; 2012 Sep; 82(5):280-2. PubMed ID: 22539249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
    Chamberlain MC; Glantz MJ
    Blood; 2007 Sep; 110(5):1698; author reply 1698-9. PubMed ID: 17712051
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of the Polish Acute Leukemia Group.
    Holowiecka-Goral A; Hołowiecki J; Giebel S; Stella-Holowiecka B; Krawczyk-Kulis M; Kos K; Lehmann-Kopydłowska A; Dudzinski M; Hałasz M; Preisner W; Cioch M; Piszcz J
    Leuk Lymphoma; 2009 Mar; 50(3):478-80. PubMed ID: 19294561
    [No Abstract]   [Full Text] [Related]  

  • 13. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Lee EJ; Petroni GR; Schiffer CA; Freter CE; Johnson JL; Barcos M; Frizzera G; Bloomfield CD; Peterson BA
    J Clin Oncol; 2001 Oct; 19(20):4014-22. PubMed ID: 11600602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
    Duarte RF; Arnan M; Sánchez-Ortega I; de Llano MP; Abellán PF
    Leuk Res; 2011 Jul; 35(7):e128-30. PubMed ID: 21501870
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intermediate dose of Ara-C (IDAra-C) for the treatment of refractory and relapsed lymphoid malignancies].
    Taniguchi S; Shibuya T; Morioka E; Ohhara N; Ohtsuka T; Hirota Y; Yamano Y; Miki K; Asano Y; Niho Y
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1453-8. PubMed ID: 3183455
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
    Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
    Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas].
    Kumiega B; Jurczak W; Fornagiel S; Dzietczenia J; Skotnicki AB
    Przegl Lek; 2013; 70(4):187-90. PubMed ID: 23991555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials referral resource. Acute lymphocytic leukemia.
    Cheson BD
    Oncology (Williston Park); 1993 May; 7(5):31-4. PubMed ID: 8512780
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal acute tumor lysis syndrome following intrathecal chemotherapy for acute lymphoblastic leukemia with meningeal involvement.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Uchimaru K; Tojo A
    Intern Med; 2008; 47(22):1987-8. PubMed ID: 19015613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
    Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.